Bioradiotherapy with Cetuximab May Reduce the Risk of Neck Node Relapse in Locoregionally Advanced Laryngeal Glottic Carcinoma: May HER1-Profile Be Useful in the Bioselection of Patients?

The aim of the study was to evaluate survival in patients with advanced glottic laryngeal squamous cell carcinoma treated by bioradiotherapy (BioRT) with cetuximab and eventual salvage surgery (group A, <i>n</i> = 66) or upfront surgery (total laryngectomy or near-total laryngectomy) wit...

Full description

Bibliographic Details
Main Authors: Giovanni Almadori, Antonella Coli, Eugenio De Corso, Stefano Settimi, Dario Antonio Mele, Francesca Brigato, Domenico Scannone, Jacopo Galli, Vincenzo Valentini, Gaetano Paludetti, Libero Lauriola, Franco Oreste Ranelletti
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Journal of Personalized Medicine
Subjects:
Online Access:https://www.mdpi.com/2075-4426/12/9/1489